Ipsen’s oral small molecule has failed to reduce the progression of a genetic disease that gradually turns tendons and ...

With all the buzzwords surrounding artificial intelligence, from smiling promotions to angry chagrins—promises that it will ...

Venture capital firm Aditum Bio is going all-out for a new collaboration with Fosun Pharma, launching a subsidiary with the ...

Earlier this month, Medtronic received a new approval from the FDA for its decades-old liquid embolic system, extending its ...

Merck & Co. is turning down its option to license Evaxion’s gonorrhea vaccine candidate, closing the door on the Danish ...